Industry News: Big Step Forward for Novartis CAR-T Cancer Therapy after FDA Backing – SelectScience
SelectScience |
Industry News: Big Step Forward for Novartis CAR–T Cancer Therapy after FDA Backing
SelectScience Novartis recently announced a unanimous recommendation of their CAR–T cell therapy CTL019 by the US Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC). CTL019 is an investigational chimeric antigen receptor T cell … |
